The United States Rheumatic Diseases Therapeutics Market

Changes on the Horizon with Novel Oral Therapies for Musculoskeletal Indications

Regular Price: USD 9,000

Special Price USD 6,750

25% OFF

* Required Fields

Regular Price: USD 9,000

Special Price USD 6,750

PAY BY INVOICE

Be the first to review this product

This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The focus of this research is on biologics and other treatments prescribed as add-on therapies for rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS); background standard of care therapies are not covered in this study. Included in the study are products already on the market and products in development as well as patient and revenue forecasts. Market challenges, drivers, and restraints are identified and assessed. The market is segmented by disease indication: RA, PsA, and AS.

Table of Contents

The United States Rheumatic Diseases Therapeutics Market, Rheumatic Diseases Therapeutics MarketAnalysis of the United States Rheumatic Diseases Therapeutics MarketExecutive Summary and Market OverviewThe United States Rheumatic Diseases Therapeutics Market, Rheumatic Diseases Therapeutics Market - Total MarketAnalysis of the Total Rheumatic Diseases Therapeutics Market Drivers and RestraintsForecasts and TrendsDemand AnalysisMarket Share and Competitive AnalysisThe United States Rheumatic Diseases Therapeutics Market, Rheumatoid Arthritis SegmentAnalysis of the Rheumatoid Arthritis SegmentSegment Breakdown and Market Engineering MeasurementsPatient ForecastPricing Trends and ForecastRevenue ForecastMarket Share Analysis The United States Rheumatic Diseases Therapeutics Market, Psoriatic Arthritis Segment Analysis of the Psoriatic Arthritis SegmentSegment Breakdown and Market Engineering MeasurementsPatient ForecastPricing Trends and ForecastRevenue ForecastMarket Share Analysis The United States Rheumatic Diseases Therapeutics Market, Ankylosing Spondylitis Segment Analysis of the Ankylosing Spondylitis SegmentSegment Breakdown and Market Engineering MeasurementsPatient ForecastPricing Trends and ForecastRevenue ForecastMarket Share Analysis The United States Rheumatic Diseases Therapeutics Market, The Last WordThe Last WordSummary and ConclusionsThe United States Rheumatic Diseases Therapeutics Market, AppendixAppendixAppendix




Related Research

Release Date : 15-Sep-17

Region : North America

Release Date : 15-Sep-17

Region : North America

Release Date : 13-Sep-17

Region : North America

Release Date : 13-Sep-17

Region : North America

Release Date : 13-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.